Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
- CAD | -.--% | -5,08% | +3,70% |
2020 | Transcript : Correvio Pharma Corp. - Shareholder/Analyst Call | |
2019 | Transcript : Correvio Pharma Corp., Q3 2019 Earnings Call, Nov 14, 2019 |
Omzet 2018 | 28,67 mln. 39,2 mln. 26,63 mln. | Omzet 2019 | 32,63 mln. 44,61 mln. 30,3 mln. | Marktkapitalisatie | 27,28 mln. 37,29 mln. 25,33 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -16 mln. -21,87 mln. -14,86 mln. | Nettowinst (verlies) 2019 | -35 mln. -47,84 mln. -32,5 mln. | EV/omzet 2018 | 5,13 x |
Nettoschuld 2018 | 25,92 mln. 35,43 mln. 24,07 mln. | Nettoschuld 2019 | 33,9 mln. 46,35 mln. 31,48 mln. | EV/omzet 2019 | 1,87 x |
K/w-verhouding 2018 |
-7,1
x | K/w-verhouding 2019 |
-0,68
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 86,23% |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ram Ramkumar
BRD | Director/Board Member | - | - |
Andreas Stickler
BRD | Director/Board Member | 53 | - |
Robert Ford
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,70% | 27,65 mln. | |
+7,91% | 72,81 mld. | |
+12,64% | 9,13 mld. | |
-10,56% | 5,13 mld. | |
+58,79% | 4,99 mld. | |
+4,07% | 3,9 mld. | |
-16,90% | 2,48 mld. | |
-26,13% | 2,32 mld. | |
+19,31% | 2,17 mld. | |
-0,50% | 1,64 mld. |